In vitro effects of peroxisome proliferator-activated receptor-γ ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells

Fertility and Sterility

Volumn 95, Issue 2, 2011, Pages

  Sharma, Indu ^a   Dhawan, Veena ^a   Saha, Subhash Chand ^a   Dhaliwal, Lakhbir Kaur ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Endometriosis; ESCs; inflammation; PPAR ; rosiglitazone

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; VASCULOTROPIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

EID: 78751580336     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.008     Document Type: Article

References (24)

1. D. Panigrahy, S. Singer, L.Q. Shen, C.E. Butterfield, D.A. Freedman, and E.J. Chen PPAR-γ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis J Clin Invest 110 2002 923 932
2. G.L. Rubin, Y. Zhao, A.M. Kalus, and E.R. Simpson Proxisome proliferator activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy Cancer Res 60 2000 1604 1608
3. U. Edvardsson, M. Bergstrom, M. Alexandersson, K. Bamberg, B. Ljung, and B. Dahllöf Rosiglitazone (BRL49653), a PPAR-γ selective agonist, causes peroxisome proliferator-like liver effects in obese mice J Lipid Res 40 1999 1177 1184
4. F. Demirturk, H. Aytan, A.C. Caliskan, P. Aytan, and D.R. Koseoglu Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model J Soc Gynecol Invest 13 2006 58 62
5. D.I. Lebovic, J.M. Mwenda, D.C. Chai, M.D. Mueller, A. Santi, and S. Fisseha PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study Fertil Steril 88 Suppl 4 2007 1108 1119
6. S. Eligini, C. Banfi, M. Brambilla, M. Camera, S.S. Barbieri, and F. Poma 15-deoxy-delta12,14-prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade Thromb Haemost 88 2002 524 532
7. L.B. Maggi Jr., H. Sadeghi, C. Weigand, A.L. Scarim, M.R. Heitmeier, and J.A. Corbett Anti-inflammatory actions of 15-deoxy-12,14-prostaglandin J2 and troglitazone evidence for heat shock-dependent and independent inhibition of cytokine-induced inducible nitric oxide synthase expression Diabetes 49 2000 346 355
8. I. Sharma, V. Dhawan, N. Mahajan, S.C. Saha, and L.K. Dhaliwal In vitro effects of atorvastatin on LPS-induced gene expression in endometriotic stromal cells Fertil Steril 94 2010 63 70
9. I. Sharma, V. Dhawan, S.C. Saha, R. Bagga, and L.K. Dhaliwal Implication of RAGE-EN-RAGE axis in endometriosis Int J Gynecol Obstet 110 2010 199 202
10. ASRM Revised American Society for Reproductive Medicine classification of endometriosis Fertil Steril 67 1997 817 821
11. J.T. Huang, J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, and C. Kelly Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase Nature 400 6742 1999 378 382
12. M. Collino, M. Aragno, R. Mastrocola, M. Gallicchio, A.C. Rosa, and C. Dianzani Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion Eur J Pharmacol 530 1-2 2006 70 80
13. H.J. Chang, J.H. Lee, K.J. Hwang, M.R. Kim, K.H. Chang, and D.W. Park Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-β1 Fertil Steril 90 Suppl 4 2008 1357 1365
14. D. Bishop-Bailey, and T.D. Warner PPAR-γ ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-γ antagonist FASEB J 17 13 2003 1925 1927
15. S. Hazra, R.K. Batra, H.H. Tai, S. Sharma, X. Cui, and S.M. Dubinett Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase Mol Pharmacol 71 2007 1715 1720
16. M. Mendez, and M.C. LaPointe PPAR-γ inhibition of cyclooxygenase-2, PGE2 synthase and inducible nitric oxide synthase in cardiac myocytes Hypertension 42 2003 844 850
17. E. Hovsepian, F. Penas, and N.B. Goren 15-Deoxy-12,14 PGJ2 but not rosiglitazone regulates MMP-9, NOS-2 and COX-2 expression and function by PPAR-gamma-dependent and independent mechanisms in cardiac cells Shock 34 2010 60 67
18. L.L.H. Peeters, J.L. Vigne, M.K. Tee, D. Zhao, L.L. Waite, and R.N. Taylor PPAR-gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis Angiogenesis 8 2005 373 379
19. M. Emoto, T. Anno, Y. Sato, K. Tanabe, S. Okuya, and Y. Tanizawa Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes Diabetes 50 2001 1166 1170
20. K.B. Sotiropoulos, A. Clermont, Y. Yasuda, C. Rask-Madsen, M. Mastumoto, and J. Takahashi Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPAR-γ agonist's effects on edema and weight gain FASEB J 20 2006 1203 1205
21. A.A. Rouzi, and M.S. Ardawi A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome Fertil Steril 85 2006 428 435
22. D.B. Klinkner, H.J. Lim, E.Y. Strawn Jr., K.T. Oldham, and T.L. Sander An in vivo murine model of rosiglitazone use in pregnancy Fertil Steril 86 Suppl 4 2006 1074 1079
23. M.B. Moravek, E.A. Ward, and D.I. Lebovic Thiazolidinediones as therapy for endometriosis: a case series Gynecol Obstet Invest 68 2009 167 170
24. 2: endogenous PPAR-γ ligand or minor eicosanoid degradation product? J Clin Invest 112 2003 828 830